Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir

Jason Comer, Olivier Escaffre, Natasha Neef, Trevor Brasel, Terry L. Juelich, Jennifer K. Smith, Jeanon Smith, Birte Kalveram, David D. Perez, Shane Massey, Lihong Zhang, Alexander Freiberg

Research output: Contribution to journalArticle

Abstract

The 2014 Ebolavirus outbreak in West Africa highlighted the need for vaccines and therapeutics to prevent and treat filovirus infections. A well-characterized small animal model that is susceptible to wild-type filoviruses would facilitate the screening of anti-filovirus agents. To that end, we characterized knockout mice lacking α/β and γ interferon receptors (IFNAGR KO) as a model for wild-type filovirus infection. Intraperitoneal challenge of IFNAGR KO mice with several known human pathogenic species from the genus Ebolavirus and Marburgvirus, except Bundibugyo ebolavirus and Taï Forest ebolavirus, caused variable mortality rate. Further characterization of the prototype Ebola virus Kikwit isolate infection in this KO mouse model showed 100% lethality down to a dilution equivalent to 1.0 × 10-1 pfu with all deaths occurring between 7 and 9 days post-challenge. Viral RNA was detectable in serum after challenge with 1.0 × 10² pfu as early as one day after infection. Changes in hematology and serum chemistry became pronounced as the disease progressed and mirrored the histological changes in the spleen and liver that were also consistent with those described for patients with Ebola virus disease. In a proof-of-principle study, treatment of Ebola virus infected IFNAGR KO mice with favipiravir resulted in 83% protection. Taken together, the data suggest that IFNAGR KO mice may be a useful model for early screening of anti-filovirus medical countermeasures.

Original languageEnglish (US)
JournalViruses
Volume11
Issue number2
DOIs
StatePublished - Feb 3 2019

Fingerprint

Ebolavirus
Knockout Mice
Interferons
Virulence
Infection
Ebola Hemorrhagic Fever
Therapeutics
Marburgvirus
Interferon Receptors
Western Africa
Viral RNA
Hematology
Serum
Disease Outbreaks
favipiravir
Vaccines
Spleen
Animal Models
Mortality
Liver

Keywords

  • Ebola virus
  • filovirus
  • interferon receptor knockout
  • mouse

ASJC Scopus subject areas

  • Infectious Diseases
  • Virology

Cite this

Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir. / Comer, Jason; Escaffre, Olivier; Neef, Natasha; Brasel, Trevor; Juelich, Terry L.; Smith, Jennifer K.; Smith, Jeanon; Kalveram, Birte; Perez, David D.; Massey, Shane; Zhang, Lihong; Freiberg, Alexander.

In: Viruses, Vol. 11, No. 2, 03.02.2019.

Research output: Contribution to journalArticle

Comer, J, Escaffre, O, Neef, N, Brasel, T, Juelich, TL, Smith, JK, Smith, J, Kalveram, B, Perez, DD, Massey, S, Zhang, L & Freiberg, A 2019, 'Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir', Viruses, vol. 11, no. 2. https://doi.org/10.3390/v11020137
Comer, Jason ; Escaffre, Olivier ; Neef, Natasha ; Brasel, Trevor ; Juelich, Terry L. ; Smith, Jennifer K. ; Smith, Jeanon ; Kalveram, Birte ; Perez, David D. ; Massey, Shane ; Zhang, Lihong ; Freiberg, Alexander. / Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir. In: Viruses. 2019 ; Vol. 11, No. 2.
@article{c04f188e7667414a8ee29253d708dbcb,
title = "Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir",
abstract = "The 2014 Ebolavirus outbreak in West Africa highlighted the need for vaccines and therapeutics to prevent and treat filovirus infections. A well-characterized small animal model that is susceptible to wild-type filoviruses would facilitate the screening of anti-filovirus agents. To that end, we characterized knockout mice lacking α/β and γ interferon receptors (IFNAGR KO) as a model for wild-type filovirus infection. Intraperitoneal challenge of IFNAGR KO mice with several known human pathogenic species from the genus Ebolavirus and Marburgvirus, except Bundibugyo ebolavirus and Ta{\"i} Forest ebolavirus, caused variable mortality rate. Further characterization of the prototype Ebola virus Kikwit isolate infection in this KO mouse model showed 100{\%} lethality down to a dilution equivalent to 1.0 × 10-1 pfu with all deaths occurring between 7 and 9 days post-challenge. Viral RNA was detectable in serum after challenge with 1.0 × 10² pfu as early as one day after infection. Changes in hematology and serum chemistry became pronounced as the disease progressed and mirrored the histological changes in the spleen and liver that were also consistent with those described for patients with Ebola virus disease. In a proof-of-principle study, treatment of Ebola virus infected IFNAGR KO mice with favipiravir resulted in 83{\%} protection. Taken together, the data suggest that IFNAGR KO mice may be a useful model for early screening of anti-filovirus medical countermeasures.",
keywords = "Ebola virus, filovirus, interferon receptor knockout, mouse",
author = "Jason Comer and Olivier Escaffre and Natasha Neef and Trevor Brasel and Juelich, {Terry L.} and Smith, {Jennifer K.} and Jeanon Smith and Birte Kalveram and Perez, {David D.} and Shane Massey and Lihong Zhang and Alexander Freiberg",
year = "2019",
month = "2",
day = "3",
doi = "10.3390/v11020137",
language = "English (US)",
volume = "11",
journal = "Viruses",
issn = "1999-4915",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "2",

}

TY - JOUR

T1 - Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir

AU - Comer, Jason

AU - Escaffre, Olivier

AU - Neef, Natasha

AU - Brasel, Trevor

AU - Juelich, Terry L.

AU - Smith, Jennifer K.

AU - Smith, Jeanon

AU - Kalveram, Birte

AU - Perez, David D.

AU - Massey, Shane

AU - Zhang, Lihong

AU - Freiberg, Alexander

PY - 2019/2/3

Y1 - 2019/2/3

N2 - The 2014 Ebolavirus outbreak in West Africa highlighted the need for vaccines and therapeutics to prevent and treat filovirus infections. A well-characterized small animal model that is susceptible to wild-type filoviruses would facilitate the screening of anti-filovirus agents. To that end, we characterized knockout mice lacking α/β and γ interferon receptors (IFNAGR KO) as a model for wild-type filovirus infection. Intraperitoneal challenge of IFNAGR KO mice with several known human pathogenic species from the genus Ebolavirus and Marburgvirus, except Bundibugyo ebolavirus and Taï Forest ebolavirus, caused variable mortality rate. Further characterization of the prototype Ebola virus Kikwit isolate infection in this KO mouse model showed 100% lethality down to a dilution equivalent to 1.0 × 10-1 pfu with all deaths occurring between 7 and 9 days post-challenge. Viral RNA was detectable in serum after challenge with 1.0 × 10² pfu as early as one day after infection. Changes in hematology and serum chemistry became pronounced as the disease progressed and mirrored the histological changes in the spleen and liver that were also consistent with those described for patients with Ebola virus disease. In a proof-of-principle study, treatment of Ebola virus infected IFNAGR KO mice with favipiravir resulted in 83% protection. Taken together, the data suggest that IFNAGR KO mice may be a useful model for early screening of anti-filovirus medical countermeasures.

AB - The 2014 Ebolavirus outbreak in West Africa highlighted the need for vaccines and therapeutics to prevent and treat filovirus infections. A well-characterized small animal model that is susceptible to wild-type filoviruses would facilitate the screening of anti-filovirus agents. To that end, we characterized knockout mice lacking α/β and γ interferon receptors (IFNAGR KO) as a model for wild-type filovirus infection. Intraperitoneal challenge of IFNAGR KO mice with several known human pathogenic species from the genus Ebolavirus and Marburgvirus, except Bundibugyo ebolavirus and Taï Forest ebolavirus, caused variable mortality rate. Further characterization of the prototype Ebola virus Kikwit isolate infection in this KO mouse model showed 100% lethality down to a dilution equivalent to 1.0 × 10-1 pfu with all deaths occurring between 7 and 9 days post-challenge. Viral RNA was detectable in serum after challenge with 1.0 × 10² pfu as early as one day after infection. Changes in hematology and serum chemistry became pronounced as the disease progressed and mirrored the histological changes in the spleen and liver that were also consistent with those described for patients with Ebola virus disease. In a proof-of-principle study, treatment of Ebola virus infected IFNAGR KO mice with favipiravir resulted in 83% protection. Taken together, the data suggest that IFNAGR KO mice may be a useful model for early screening of anti-filovirus medical countermeasures.

KW - Ebola virus

KW - filovirus

KW - interferon receptor knockout

KW - mouse

UR - http://www.scopus.com/inward/record.url?scp=85061063592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061063592&partnerID=8YFLogxK

U2 - 10.3390/v11020137

DO - 10.3390/v11020137

M3 - Article

VL - 11

JO - Viruses

JF - Viruses

SN - 1999-4915

IS - 2

ER -